Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China · Delayed Price · Currency is CNY 28.76
+0.75 (2.68%)
Sep 21, 2026, 3:00 PM CST
SHA:603882 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,233 | 2,851 | 2,434 | 2,458 | 2,929 | 2,653 |
Cash & Short-Term Investments | 2,243 | 2,851 | 2,434 | 2,458 | 2,929 | 2,653 |
Cash Growth | 3.05% | 17.17% | -0.98% | -16.08% | 10.37% | 62.26% |
Accounts Receivable | 3,500 | 3,376 | 4,429 | 5,399 | 7,136 | 4,804 |
Other Receivables | 82.14 | 85.94 | 82.71 | 76.98 | 91.65 | 66.1 |
Receivables | 3,583 | 3,462 | 4,512 | 5,476 | 7,227 | 4,870 |
Inventory | 185.93 | 186.1 | 198.32 | 248.21 | 405.25 | 345.14 |
Prepaid Expenses | 55.85 | 40.98 | 38.44 | 47.43 | 48.94 | 43 |
Other Current Assets | 78.72 | 72.93 | 136.02 | 35.5 | 49.49 | 18.74 |
Total Current Assets | 6,147 | 6,613 | 7,318 | 8,265 | 10,660 | 7,930 |
Property, Plant & Equipment | 1,939 | 1,905 | 1,968 | 2,305 | 2,215 | 1,968 |
Long-Term Investments | 393.46 | 405.52 | 425.03 | 554.25 | 353.63 | 358.32 |
Goodwill | 42.06 | 42.06 | 52.21 | 52.21 | 32.68 | 13.35 |
Other Intangible Assets | 174.09 | 175.08 | 167.54 | 150.33 | 152 | 68.41 |
Long-Term Deferred Tax Assets | 308 | 310 | 241.42 | 151.11 | 86.34 | 36.11 |
Long-Term Deferred Charges | 94.39 | 124.05 | 184.74 | 245.24 | 255.19 | 197.69 |
Other Long-Term Assets | 40.74 | 29.47 | 34.28 | 44.15 | 137.95 | 179.11 |
Total Assets | 9,139 | 9,605 | 10,392 | 11,768 | 13,893 | 10,751 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,475 | 1,486 | 1,716 | 2,065 | 2,988 | 2,283 |
Accrued Expenses | 187.34 | 258.4 | 260.1 | 355.61 | 995.92 | 834.42 |
Short-Term Debt | - | - | 1 | 1 | - | - |
Current Portion of Long-Term Debt | 114.02 | 112.39 | 37.82 | 14.83 | 137.66 | 130.93 |
Current Portion of Leases | 54.4 | 54.88 | 76.25 | 115.51 | 84 | 70.04 |
Current Income Taxes Payable | 26.31 | 30.29 | 59.16 | 15.49 | 231.97 | 228.13 |
Current Unearned Revenue | 62.53 | 64.04 | 54.84 | 76.78 | 104.62 | 131.8 |
Other Current Liabilities | 43.02 | 35.98 | 27.1 | 44.82 | 38 | 50.03 |
Total Current Liabilities | 1,962 | 2,042 | 2,232 | 2,689 | 4,580 | 3,728 |
Long-Term Debt | 575.03 | 575.74 | 514.93 | 267.61 | 143 | 248.74 |
Long-Term Leases | 117.66 | 92.64 | 118.39 | 180.26 | 203.63 | 172.39 |
Long-Term Unearned Revenue | 15.15 | 14.6 | 22.38 | 24.97 | 24.42 | 37.45 |
Long-Term Deferred Tax Liabilities | 18.77 | 20.85 | 28.71 | 58.26 | 64.4 | 41.63 |
Total Liabilities | 2,689 | 2,746 | 2,917 | 3,220 | 5,016 | 4,228 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 463.26 | 463.26 | 463.26 | 468.77 | 467.14 | 465.59 |
Additional Paid-In Capital | 1,170 | 1,170 | 1,171 | 1,515 | 1,517 | 1,377 |
Retained Earnings | 4,856 | 5,073 | 5,654 | 6,443 | 6,632 | 4,473 |
Treasury Stock | -173.44 | - | - | -89.99 | - | - |
Comprehensive Income & Other | -1.06 | 23.11 | 36.66 | 26.03 | 18.04 | -11.76 |
Total Common Equity | 6,314 | 6,729 | 7,325 | 8,363 | 8,633 | 6,304 |
Minority Interest | 135.39 | 129.16 | 149.8 | 184.56 | 243.4 | 218.78 |
Shareholders' Equity | 6,450 | 6,859 | 7,475 | 8,547 | 8,877 | 6,523 |
Total Liabilities & Equity | 9,139 | 9,605 | 10,392 | 11,768 | 13,893 | 10,751 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 861.11 | 835.65 | 748.39 | 579.21 | 568.3 | 622.1 |
Net Cash (Debt) | 1,382 | 2,016 | 1,685 | 1,878 | 2,360 | 2,031 |
Net Cash Growth | -1.59% | 19.61% | -10.29% | -20.42% | 16.20% | 66.65% |
Net Cash Per Share | 2.98 | 4.30 | 3.62 | 4.03 | 5.06 | 4.36 |
Filing Date Shares Outstanding | 456.64 | 463.26 | 463.26 | 464.79 | 467.3 | 465.59 |
Total Common Shares Outstanding | 456.64 | 463.26 | 463.26 | 468.12 | 467.14 | 465.59 |
Working Capital | 4,184 | 4,571 | 5,086 | 5,576 | 6,079 | 4,202 |
Book Value Per Share | 13.83 | 14.53 | 15.81 | 17.86 | 18.48 | 13.54 |
Tangible Book Value | 6,098 | 6,512 | 7,106 | 8,160 | 8,449 | 6,222 |
Tangible Book Value Per Share | 13.35 | 14.06 | 15.34 | 17.43 | 18.09 | 13.36 |
Buildings | 762.87 | 762.87 | 748.83 | 658.02 | 577.61 | 570.99 |
Machinery | 2,438 | 2,432 | 2,503 | 2,945 | 2,748 | 2,237 |
Construction In Progress | 824.57 | 731.32 | 527.95 | 359.11 | 205.53 | 143.15 |